Impact of Diagnosis-Related Groups (DRG) reform on cost homogeneity of treatment for patients with malignant tumours

Abstract The cost fluctuations associated with chemotherapy, radiotherapy, and immunotherapy, as primary modalities for treating malignant tumors, are closely related to medical decision-making and impose financial burdens on patients. In response to these challenges, China has implemented the Diagn...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyue Zheng, Xiaoyue Xiao, Keyi Shen, Tong Pei, Xinhao Lin, Wen Liu, Dan Wu, Xuehui Meng
Format: Article
Language:English
Published: Nature Portfolio 2024-09-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-71917-y
Tags: Add Tag
No Tags, Be the first to tag this record!